{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:37:58Z","timestamp":1790350678134,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T00:00:00Z","timestamp":1166659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T00:00:00Z","timestamp":1166659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication seen in patients with autoimmune disorders and patients treated with chemotherapy or after hematopoietic stem cell transplantation. The clinical management of DAH is complex and the condition has a high mortality rate. Tissue factor is expressed in the lung alveoli during inflammation and therefore pulmonary administration of human recombinant activated factor VIIa (rFVIIa) could be a rational treatment option.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Six patients with acute, bronchoscopically confirmed DAH from a single intensive care unit university hospital center were included in the study of acute DAH in critically ill patients. The patients were treated with intrapulmonary administration of 50 \u03bcg\/kg rFVIIa in 50 ml of sodium chloride by bronchoalveolar lavage (BAL) with 25 ml in each of the main bronchi, which was repeated after 24 hours in case of treatment failure.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>An excellent response, defined as complete and sustained hemostasis after a single dose of rFVIIa, was seen in three patients. A good response, meaning that sustained hemostasis was achieved by a repeated rFVIIa administration, was seen in the remaining three patients. In one of these patients, the BAL treatment was repeated twice; in another patient, the second dose of rFVIIa was administered by nebulizer after extubation after the initial BAL. The hemostatic effect was statistically significant (<jats:italic>p<\/jats:italic> = 0.031). The oxygenation capacity, as reflected by the PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> (arterial oxygen pressure\/inspiratory fractional oxygen content) ratio, increased significantly (<jats:italic>p<\/jats:italic> = 0.024) in all six patients following the local rFVIIa therapy.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Symptomatic therapy of DAH after intrapulmonary administration of one or more doses of rFVIIa was found to have a good to excellent hemostatic effect in six consecutive patients with DAH. The intrapulmonary administration of rFVIIa seemed to have a high benefit-to-risk ratio. Larger series should confirm the safety of this approach.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc5132","type":"journal-article","created":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T19:13:57Z","timestamp":1166728437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage"],"prefix":"10.1186","volume":"10","author":[{"given":"Lars","family":"Heslet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorn Dalsgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sengel\u00f8v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r I","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,21]]},"reference":[{"key":"4646_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/00003246-200004000-00017","volume":"28","author":"AJ Huaringa","year":"2000","unstructured":"Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE: Outcome of bone marrow transplantation patients requiring mechanical ventilation.\n                           Crit Care Med 2000, 28: 1014-1017. 10.1097\/00003246-200004000-00017","journal-title":"Crit Care Med"},{"key":"4646_CR2","first-page":"1006","volume":"151","author":"C Agusti","year":"1995","unstructured":"Agusti C, Ramirez J, Picado C, Xaubet A, Carreras E, Ballester E, Torres A, Battochia C, Rodriguez-Roisin R: Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study.\n                           Am J Respir Crit Care Med 1995, 151: 1006-1110.","journal-title":"Am J Respir Crit Care Med"},{"key":"4646_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.bmt.1702546","volume":"26","author":"ID Lewis","year":"2000","unstructured":"Lewis ID, Defor T, Weisdorf DJ: Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.\n                           Bone Marrow Transplant 2000, 26: 539-543. 10.1038\/sj.bmt.1702546","journal-title":"Bone Marrow Transplant"},{"key":"4646_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1164\/ajrccm.158.1.9709007","volume":"158","author":"M Levi","year":"1998","unstructured":"Levi M, van Der Poll T, ten Cate H, Kuipers B, Biemond BJ, Jansen HM, ten Cate JW: Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.\n                           Am J Respir Crit Care Med 1998, 158: 92-98.","journal-title":"Am J Respir Crit Care Med"},{"key":"4646_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/sj.bmt.1702335","volume":"25","author":"AJ Huaringa","year":"2000","unstructured":"Huaringa AJ, Leyva FJ, Signes-Costa J, Morice RC, Raad I, Darwish AA, Champlin RE: Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplantation patients.\n                           Bone Marrow Transplant 2000, 25: 975-980. 10.1038\/sj.bmt.1702335","journal-title":"Bone Marrow Transplant"},{"key":"4646_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/sj.leu.2402921","volume":"17","author":"DJ Weisdorf","year":"2003","unstructured":"Weisdorf DJ: Diffuse alveolar hemorrhage: an evolving problem?\n                           Leukemia 2003, 17: 1049-1050. 10.1038\/sj.leu.2402921","journal-title":"Leukemia"},{"key":"4646_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.bmt.1701995","volume":"24","author":"A Raptis","year":"1999","unstructured":"Raptis A, Mavroudis D, Suffredini A, Molldrem J, Rhee FV, Childs R, Phang S, Barrett A: High-dose corticosteroid therapy for diffuse alveolar hemorrhage in alloeneic bone marrow stem cell transplant recipients.\n                           Bone Marrow Transplant 1999, 24: 879-883. 10.1038\/sj.bmt.1701995","journal-title":"Bone Marrow Transplant"},{"key":"4646_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00002281-200101000-00003","volume":"13","author":"U Speck","year":"2001","unstructured":"Speck U: Diffuse alveolar hemorrhage syndromes.\n                           Curr Opin Rheumatol 2001, 13: 12-17. 10.1097\/00002281-200101000-00003","journal-title":"Curr Opin Rheumatol"},{"key":"4646_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1046\/j.1538-7836.2003.00225.x","volume":"1","author":"T Lisman","year":"2003","unstructured":"Lisman T, de Groot PH: Mechanism of action of recombinant factor VIIa.\n                           J Thromb Haemost 2003, 1: 1138-1139. 10.1046\/j.1538-7836.2003.00225.x","journal-title":"J Thromb Haemost"},{"key":"4646_CR10","first-page":"39","volume":"49","author":"U Hedner","year":"2003","unstructured":"Hedner U: Recombinant factor VIIa (NovoSeven) as a hemostatic agent.\n                           Dis Mon 2003, 49: 39-48.","journal-title":"Dis Mon"},{"key":"4646_CR11","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1378\/chest.124.6.2400","volume":"124","author":"SM Pastores","year":"2003","unstructured":"Pastores SM, Papadopoulos E, Voigt L, Halpern NA: Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.\n                           Chest 2003, 124: 2400-2403. 10.1378\/chest.124.6.2400","journal-title":"Chest"},{"key":"4646_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/sj.bmt.1703731","volume":"30","author":"K Hicks","year":"2002","unstructured":"Hicks K, Peng D, Gajewski JL: Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.\n                           Bone Marrow Transplant 2002, 30: 975-978. 10.1038\/sj.bmt.1703731","journal-title":"Bone Marrow Transplant"},{"key":"4646_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-140-6-200403160-00033","volume":"140","author":"D Henke","year":"2004","unstructured":"Henke D, Falk RJ, Gabriel DA: Successful treatment of diffuse alveolar hemorrhage with activated Factor VII.\n                           Ann Intern Med 2004, 140: 493-494.","journal-title":"Ann Intern Med"},{"key":"4646_CR14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.CCM.0000201882.23917.B8","volume":"34","author":"MJ Schultz","year":"2006","unstructured":"Schultz MJ, Haitsma JJ, Zhang H, Slutsky A: Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia.\n                           Crit Care Med 2006, 34: 871-877.","journal-title":"Crit Care Med"},{"key":"4646_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/thorax.2003.013888","volume":"59","author":"MJ Schultz","year":"2004","unstructured":"Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia.\n                           Thorax 2004, 59: 130-135. 10.1136\/thorax.2003.013888","journal-title":"Thorax"},{"key":"4646_CR16","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1097\/01.CCM.0000057849.53689.65","volume":"31","author":"M Levi","year":"2003","unstructured":"Levi M, Schultz MJ, Rijneveld AJ, van der Poll T: Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia.\n                           Crit Care Med 2003, 31: S238-S242. 10.1097\/01.CCM.0000057849.53689.65","journal-title":"Crit Care Med"},{"key":"4646_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1164\/ajrccm\/151.3_Pt_1.758","volume":"151","author":"AK Sabharwal","year":"1995","unstructured":"Sabharwal AK, Bajaj SP, Ameri A, Tricomi SM, Hyers TM, Dahms TE, Taylor FB Jr, Bajaj MS: Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.\n                           Am J Respir Crit Care Med 1995, 151: 758-767.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc5132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc5132\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc5132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:56:40Z","timestamp":1728305800000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc5132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,21]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,12]]}},"alternative-id":["4646"],"URL":"https:\/\/doi.org\/10.1186\/cc5132","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,21]]},"assertion":[{"value":"5 October 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R177"}}